Maitland Scott B, Brauer Paula, Mutch David M, Royall Dawna, Klein Doug, Tremblay Angelo, Rheaume Caroline, Jeejeebhoy Khursheed
Department of Family Relations & Applied Nutrition, University of Guelph, 50 Stone Road, Guelph, ON, N1G 2W1, Canada.
Department of Human and Health Nutritional Sciences, University of Guelph, Guelph, ON, Canada.
BMC Prim Care. 2024 Oct 1;25(1):357. doi: 10.1186/s12875-024-02608-w.
Substantial variability in response to lifestyle interventions has been recognized for many years, and researchers have begun to disentangle sources of error from inherent differences in individual responsiveness. The objective of this secondary analysis of an intensive lifestyle intervention (diet and exercise) for metabolic syndrome (MetS) was to identify potentially important differences among study completers grouped by treatment response as measured by change in a continuous metabolic syndrome score (Gurka/MetS).
All study completers from a 12-month primary care study were categorized into one of five groups according to change in the Gurka/MetS score. A change of 0.4 in z-score defined clinically relevant change in line with results of previous studies. Repeated measures analysis of variance was used to examine cardiovascular disease risk and individual clinical indicators of MetS over 12 months, looking for differences in response over time by the five groups.
Of 176 participants, 50% (n = 88) had stable scores, 10% (n = 18) had relevant change scores in the first 3 months only and reverted toward baseline, 20% (n = 35) achieved meaningful change over the whole study, 11% (n = 20) had a delayed response at 3-12 months, and 9% (n = 15) demonstrated worsening scores. Significant differential patterns were noted for groups over the duration of the intervention (p < .001). Improvement in diet quality and fitness scores were similar across all groups. Other available variables were tested and did not account for the differences.
Work is needed to identify key factors that account for differences in responses to lifestyle interventions that can be used to guide treatment decisions for intensive lifestyle interventions for this common condition.
ClinicalTrials.gov Identifier: NCT01616563; first registered June 12, 2012.
多年来人们已经认识到生活方式干预的反应存在很大差异,研究人员已开始从个体反应性的内在差异中梳理出误差来源。这项针对代谢综合征(MetS)的强化生活方式干预(饮食和运动)的二次分析的目的是,确定按连续代谢综合征评分(Gurka/MetS)变化衡量的治疗反应分组的研究完成者之间潜在的重要差异。
一项为期12个月的初级保健研究中的所有研究完成者,根据Gurka/MetS评分的变化被分为五组之一。z评分变化0.4被定义为符合先前研究结果的临床相关变化。采用重复测量方差分析来检查12个月内的心血管疾病风险和MetS的个体临床指标,以寻找五组随时间的反应差异。
176名参与者中,50%(n = 88)评分稳定,10%(n = 18)仅在最初3个月有相关变化评分,之后又恢复到基线水平,20%(n = 35)在整个研究中实现了有意义的变化,11%(n = 20)在3至12个月时有延迟反应,9%(n = 15)表现出评分恶化。在干预期间,各组之间存在显著的差异模式(p < 0.001)。所有组的饮食质量和健康评分改善情况相似。对其他可用变量进行了测试,但它们并不能解释这些差异。
需要开展工作来确定导致生活方式干预反应差异的关键因素,这些因素可用于指导针对这种常见病症的强化生活方式干预的治疗决策。
ClinicalTrials.gov标识符:NCT01616563;首次注册于2012年6月12日。